Clinical Analysis of Primary Malignant Lymphoma of the Lung.
- Author:
Jae Bum KIM
1
;
Chang Kwon PARK
;
Nam Hee PARK
;
Dong Yoon KUM
;
Dong Sub NOH
;
Jae Hoon LEE
;
Seung Bum HAN
;
Hye Ra JUNG
Author Information
1. Department of Thoracic and Cardiovascular Surgery, Dongsan Medical Center, Keimyung University School of Medicine, Korea. ckpark80@dsmc.or.kr
- Publication Type:Original Article
- Keywords:
Lymphoma;
Pathology;
Lung neoplasm
- MeSH:
Biopsy;
Biopsy, Needle;
Drug Therapy;
Female;
Follow-Up Studies;
Humans;
Lung Neoplasms;
Lung*;
Lymphoma*;
Lymphoma, B-Cell;
Lymphoma, B-Cell, Marginal Zone;
Lymphoma, Follicular;
Male;
Needles;
Pathology;
Prognosis;
Radiotherapy;
Retrospective Studies
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2007;40(6):435-440
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Primary malignant lymphoma of the lung is a very rare neoplasm. Although the prognosis of lymphoma is favorable, the clinical features, prognostic factors and management have not been clearly defined. MATERIAL AND METHOD: We retrospectively reviewed the records of 8 patients we managed between 1994 and 2006. They all had malignant lymphoma on the pathologic examination of the lung with no evidence of mediastinal adenopathy and extrathoracic disease, and no past history of lymphoma. RESULT: The study group consisted of 3 males and 5 female patients with a mean age of 53.9 years. Three patients were asymtomatic and 5 patients were seen with pulmonary or systemic symptoms. The diagnostic methods were 3 CT needle aspiration biopsies, 1 bronchoscopic biopsy and 4 surgical methods (wedge resection, lobectomy). There were 3 patients with MALT lymphoma, two with diffuse large B-cell lymphoma, two with small lymphocytic lymphom, and one with follicular lymphoma. The 8 patients were treated with a variety of modalities, including surgery, chemotherapy, radiotherapy and combination therapy. The 8 patients have survived for a median follow-up of 38 months. CONCLUSION: Although this entity of lymphoma appears to have a good prognosis, further clinical experience and long-term follow-up are needed to identify its clinical features, prognostic factors and management.
